Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease
Top Cited Papers
- 26 September 2000
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 55 (6) , 811-815
- https://doi.org/10.1212/wnl.55.6.811
Abstract
Objective: To improve diagnostic criteria for sporadic Creutzfeldt–Jakob disease (CJD). Methods: Pooled data on initial and final diagnostic classification of suspected CJD patients were accumulated, including results of investigations derived from a coordinated multinational study of CJD. Prospective analysis for a comparison of clinical and neuropathologic diagnoses and evaluation of the sensitivity and specificity of EEG and 14-3-3 CSF immunoassay were conducted. Results: Data on 1,003 patients with suspected CJD were collected using a standard questionnaire. After follow-up was carried out, complete clinical data and neuropathologic diagnoses were available in 805 cases. In these patients, the sensitivity of the detection of periodic sharp wave complexes in the EEG was 66%, with a specificity of 74%. The detection of 14-3-3 proteins in the CSF correlated with the clinical diagnosis in 94% (sensitivity). The specificity (84%) was higher than that of EEG. A combination of both investigations further increased the sensitivity but decreased the specificity. Conclusions: Incorporation of CSF 14-3-3 analysis in the diagnostic criteria for CJD significantly increases the sensitivity of case definition. Amended diagnostic criteria for CJD are proposed.Keywords
This publication has 21 references indexed in Scilit:
- Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjectsAnnals of Neurology, 1999
- Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samplesThe Lancet, 1999
- Descriptive epidemiology of Creutzfeldt‐Jakob disease in six european countries, 1993–1995Annals of Neurology, 1998
- Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob diseaseAnnals of Neurology, 1998
- The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform EncephalopathiesNew England Journal of Medicine, 1996
- Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases)Brain Pathology, 1995
- Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted diseaseAnnals of Neurology, 1994
- High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1992
- Fatal Familial Insomnia and Dysautonomia with Selective Degeneration of Thalamic NucleiNew England Journal of Medicine, 1986
- Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clusteringAnnals of Neurology, 1979